Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Medical marijuana research

Natasha K.J. Campbell
CMAJ August 09, 2016 188 (11) 822; DOI: https://doi.org/10.1503/cmaj.1150111
Natasha K.J. Campbell
Research coordinator, McGill University, Montréal, Que.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Research in the medical marijuana field is burgeoning as governments consider changing policy in favour of legalizing the marijuana plant Cannabis sativa.1 Like any modern research effort, the gold standard for assessing a new treatment for efficacy compares the treatment to a placebo group. However, controlling for the placebo effects of marijuana may be extremely difficult, and several confounding effects must be considered.

The placebo effect is an improvement in health or behaviour that engulfs a biopsychosocial phenomenon attributable to the placebo and treatment context. On the psychosocial end of the placebo effect spectrum, “the meaning effect” is a similar notion that pertains to the meaning attached to the treatment, as well as the setting and the context of the medical encounter. On the psychobiological end of the spectrum, researchers highlight the central role of expectation, suggestion and conditioning in placebo-related phenomena. New treatments are compared to placebos because placebo effects are very strong — often stronger than the effects of the treatment.

With marijuana, several placebo effects come into play.

Marijuana has a distinct smell and taste, which may elicit classical conditioning responses. Placebo science research holds strong evidence for the effect of classical conditioning related to odour and taste: caffeine-associated stimuli, like the smell and taste of coffee, for example, are shown to increase skin conductance responses and startle eyeblink reflexes in the absence of caffeine. In addition, visual cues associated with smoking marijuana, such as cigarettes, smoke or lighters, may elicit the placebo effect and still remain a factor in even the most well-controlled recent studies.2,3

The method of marijuana administration and dose in new trials can carry powerful placebo effects. Will the marijuana be inhaled, injected, or administered topically or sublingually? Placebo science shows that placebo injections work better than placebo pills, and that four placebos work better than two. The strength of the effect of marijuana may differ greatly depending on the method of administration. Medical marijuana research describes several routes of administration, including injecting the psychoactive ingredient delta-9-tetrahydrocannabinol (THC), taking an oral THC capsule or spray, and smoking a marijuana pipe or cigarette. These differing methods of administration will each carry their own placebo effects; grouping such findings together should be avoided.

There is a way to overcome the interference between treatment and placebo effects of marijuana. We can take these lessons from placebo analgesia studies. Studies comparing hidden treatments (e.g., using a computer-controlled infusion machine that is preprogrammed to dispense medication at a desired time) with open administration (where medication is given overtly by a physician or nurse) can eliminate the placebo component. Because patients do not know that the drug is being injected, expectations of a therapeutic response are eliminated. Indeed, a trial conducted by Benedetti and colleagues4 showed that a cholecystokinin (CCK) antagonist induced stronger analgesia than a placebo, suggesting that it was a good analgesic. However, this conclusion proved to be erroneous, because a hidden injection of the same CCK antagonist was totally ineffective, showing that it had no intrinsic analgesic pharmacodynamic action; instead, it enhanced placebo-activated release of endogenous opioids.5,6 If similar studies are replicated with THC, researchers may be able to elucidate the pain-relieving properties of marijuana’s primary psychoactive ingredient.

The marijuana research field is new. Standardized methods need to be developed so researchers can properly evaluate the effectiveness of this treatment for various disorders. Controlling for the powerful placebo effects of marijuana will bring the scientific community one step closer to identifying which conditions this treatment may be most useful for, and how it is best administered.

References

  1. ↵
    1. Lough S
    . Growing the evidence base for medical cannabis. CMAJ 2015;187:955–6.
    OpenUrlFREE Full Text
  2. ↵
    1. Wilsey B,
    2. Marcotte T,
    3. Tsodikov A,
    4. et al
    . A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain 2008;9:506–21.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Ware MA,
    2. Wang T,
    3. Shapiro S,
    4. et al
    . Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 2010;182:E694–E701.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Benedetti F,
    2. Amanzio M,
    3. Maggi G
    . Potentiation of placebo analgesia by proglumide. Lancet 1995;346:1231.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Benedetti F,
    2. Mayberg HS,
    3. Wager TD,
    4. et al
    . Neurobiological mechanisms of the placebo effect. J Neurosci 2005;25:10390–402.
    OpenUrlFREE Full Text
  6. ↵
    1. Benedetti F,
    2. Maggi G,
    3. Lopiano L,
    4. et al
    . Open versus hidden medical treatments: the patient’s knowledge about a therapy affects the therapy outcome. Prev Treatment 2003:6.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 188 (11)
CMAJ
Vol. 188, Issue 11
9 Aug 2016
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Medical marijuana research
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Medical marijuana research
Natasha K.J. Campbell
CMAJ Aug 2016, 188 (11) 822; DOI: 10.1503/cmaj.1150111

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Medical marijuana research
Natasha K.J. Campbell
CMAJ Aug 2016, 188 (11) 822; DOI: 10.1503/cmaj.1150111
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Growing the evidence base for medical cannabis
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Virtual care and emergency department use
  • The denial of racism is racism itself
  • An expanded role for blood donor emerging pathogens surveillance
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire